YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Regeneron to buy 23andMe for $256M

Posted online

Drugmaker Regeneron Pharmaceuticals is set to buy genetic testing firm 23andMe through bankruptcy proceedings.

The deal is valued at $256 million.

23andMe has collected genetic data from some 15 million customers.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences